Table 1.
Variables | Entire Sample (N=154) |
PEG-Free at 12 Months (N=115) |
PEG-Dependent at 12 Months (N=39) |
P-Value |
---|---|---|---|---|
Patient Characteristics | Mean (SD, Range) or (%) | |||
Age | 59.6 (10.6, 31- 85) |
60.3 (10.7) | 57.6 (10.1) | .056 |
Gender (%) | .260 | |||
Male | 116 (75.3) | 84 (73.0) | 32 (82.1) | |
Female | 38 (24.7) | 31 (27.0) | 7 (17.9) | |
Race (%) | .026 | |||
White | 128 (83.1) | 100 (87.0) | 28 (71.8) | |
African-American | 25 (16.2) | 14 (12.2) | 11 (28.2) | |
Asian | 1 (0.6) | 1 (0.9) | ||
Partner Status | .002 | |||
With Partner | 97 (63.0) | 81 (70.4) | 16 (41.0) | |
Without Partner | 57 (37.0) | 34 (29.6) | 23 (59.0) | |
Insurance Status | .071 | |||
Insured | 130 (84.4) | 101 (87.8) | 29 (74.4) | |
Uninsured | 24 (15.6) | 14 (12.2) | 10 (25.5) | |
Tumor Characteristics | ||||
Site | .112 | |||
Oral Cavity | 54 (35.1) | 44 (38.3) | 10 (25.6) | |
Oropharynx | 57 (37.0) | 38 (33.0) | 19 (48.7) | |
Hypopharynx | 6 (3.9) | 4 (3.5) | 2 (5.1) | |
Larynx | 36 (23.4) | 28 (24.3) | 8 (20.5) | |
Hypopharynx/Oral Cavity | 1 (0.6) | 1 (0.9) | 0 | |
Tumor Stage (T Classification) |
.062 | |||
T1 | 6 (3.9) | 6 (5.2) | 0 | |
T2 | 35 (22.7) | 29 (25.2) | 6 (15.4) | |
T3 | 53 (34.4) | 40 (34.8) | 13 (33.3) | |
T4 | 56 (36.4) | 36 (31.3) | 20 (51.3) | |
TX | 4 (2.6) | 4 (3.5) | 0 | |
Overall Stage (N=152) | .783 | |||
I | 2 (1.3) | 2 (1.8) | 0 | |
II | 14 (9.2) | 11 (9.7) | 3 (7.7) | |
III | 34 (22.4) | 26 (23.0) | 8 (20.5) | |
IV | 102 (67.1) | 74 (65.5) | 28 (71.8) | |
Treatment
Characteristics |
||||
Surgery | 103 (66.9) | 78 (67.8) | 25 (64.1) | .669 |
Free Flap | 82 (53.2) | 61 (53.0) | 21 (53.8) | .991 |
Salvage Surgery | 23 (14.9) | 16 (13.9) | 7 (28.0) | .726 |
Radiation** | 122 (79.2) | 85 (73.9) | 37 (94.9) | .005 |
Primary | 51 (33.1) | 37 (32.2) | 14 (35.9) | .669 |
Post-operative | 48 (31.2) | 32 (27.8) | 16 (41.0) | .124 |
Chemotherapy | 58 (37.7) | 38 (33.0) | 20 (51.3) | .056 |
TrTracheotomy Tube
Dependence >30 days |
13 (8.4) | 5 (4.3) | 8 (20.5) | .004 |